Recombinant herpes simplex gD vaccine
US5612041A · kind A · utility
42Cited by
11References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 27, 1994 |
| Grant date | Mar 18, 1997 |
| Priority date | — |
| Expiry date | Sep 27, 2014 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/16622
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Vaccines against Herpes Simplex virus containing recombinant polypeptides which are cross-reactive with glycoprotein D of the virus, methods for their production using recombinant DNA techniques in yeast, and methods for the use of the vaccine are provided. E. coli strains HB101 containing plasmids pYHS 109 and pYHS118 were deposited at the American Type Culture Collection on Jul. 11, 1984, and granted accession nos. 39762 and 39763, respectively.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.